Naturally acquired HPV antibodies against subsequent homotypic infection: A large-scale prospective cohort study

• Egile Nagusiak: Xingmei Yao (Egilea), Wen Chen (Egilea), Chao Zhao (Egilea), Lihui Wei (Egilea), Yuemei Hu (Egilea), Mingqiang Li (Egilea), Zhijie Lin (Egilea), Bizhen Lin (Egilea), Xiaohui Liu (Egilea), Ying Hong (Egilea), Qing Li (Egilea), Qinjing Pan (Egilea), Xun Zhang (Egilea), Mingzhu Li (Egilea), Yuqian Zhao (Egilea), Li Zhang (Egilea), Huifang Xu (Egilea), Fangfang Hu (Egilea), Jun Zhao (Egilea), Yue Huang (Egilea), Wei Sheng (Egilea), Ya Zheng (Egilea), Shangying Hu (Egilea), Yingying Su (Egilea), Shoujie Huang (Egilea), Huirong Pan (Egilea), Fanghui Zhao (Egilea), Youlin Qiao (Egilea), Ting Wu (Egilea), Jun Zhang (Egilea), Ningshao Xia (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2021-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Summary: Background: Although recent studies have suggested that naturally acquired Human papillomavirus (HPV) antibodies are partly protective against subsequent homotypic infection, the extent of protection remains indecisive. Here, we evaluate the protective effect of neutralizing and IgG antibod...